Neovasc, Inc.
Neovasc, Inc.: Neovasc Reducer Therapy for Refractory Angina Marks 300th Patient Milestone in Germany 25Sep2020 / 15:51 CET/CEST
Neovasc Reducer Therapy for Refractory Angina Marks 300th Patient Milestone in Germany
VANCOUVER, MINNEAPOLIS and FRANKFURT, via NewMediaWire Neovasc, Inc. \Neovasc\ or the \Company\ NASDAQ, TSX: NVCN, today announced that the 300th... Lire le communiqué |